These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10465354)
1. Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet. Díaz-Zagoya JC; Asenjo-Barrón JC; Cárdenas-Vázquez R; Martínez F; Juárez-Oropeza MA Life Sci; 1999; 65(9):947-56. PubMed ID: 10465354 [TBL] [Abstract][Full Text] [Related]
2. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Jones P; Kafonek S; Laurora I; Hunninghake D Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454 [TBL] [Abstract][Full Text] [Related]
3. High lovastatin doses combined with hypercholesterolemic diet induce hepatic damage and are lethal to the CD-1 mouse. Asenjo-Barrón JC; Cárdenas-Vásquez R; Martínez F; Juárez-Oropeza MA; Díaz-Zagoya JC Life Sci; 1999; 64(23):2155-61. PubMed ID: 10372657 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462 [TBL] [Abstract][Full Text] [Related]
5. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Pincus J Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683 [No Abstract] [Full Text] [Related]
7. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats. Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905 [TBL] [Abstract][Full Text] [Related]
8. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs. Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500 [TBL] [Abstract][Full Text] [Related]
9. Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats. Itagaki M; Takaguri A; Kano S; Kaneta S; Ichihara K; Satoh K J Pharmacol Sci; 2009 Jan; 109(1):94-101. PubMed ID: 19129682 [TBL] [Abstract][Full Text] [Related]
10. [Which statin is more efficient? Concepts and applications in economic evaluation]. García-Altés A; Jovell AJ Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606 [No Abstract] [Full Text] [Related]
11. Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits. Gámez R; Mendoza S; Mas R; Noa M; Arruzazabala L; Carbajal D; Castaño G; Goicochea E; Mesa M; Mendoza N Drugs R D; 2003; 4(4):219-29. PubMed ID: 12848586 [TBL] [Abstract][Full Text] [Related]
12. The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys. Hartman HA; Myers LA; Evans M; Robison RL; Engstrom RG; Tse FL Fundam Appl Toxicol; 1996 Jan; 29(1):48-62. PubMed ID: 8838639 [TBL] [Abstract][Full Text] [Related]
13. Influence of high cholesterol diet and pravastatin sodium on the initiation of liver regeneration in rats after partial hepatectomy. Zivna H; Zivny P; Palicka V; Simakova E Nutrition; 2002 Jan; 18(1):51-5. PubMed ID: 11827765 [TBL] [Abstract][Full Text] [Related]
14. The rule of 5 and the rule of 7 in lipid-lowering by statin drugs. Roberts WC Am J Cardiol; 1997 Jul; 80(1):106-7. PubMed ID: 9205036 [No Abstract] [Full Text] [Related]
15. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
16. Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice. Blé-Castillo JL; Rodríguez-Hernández A; Miranda-Zamora R; Juárez-Oropeza MA; Díaz-Zagoya JC Life Sci; 2002 Apr; 70(22):2665-73. PubMed ID: 12269393 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of three statins at lower maintenance doses. Carr-Lopez S; Exstrum T; Morse T; Shepherd M; Bush AC Clin Ther; 1999 Feb; 21(2):331-9. PubMed ID: 10211536 [TBL] [Abstract][Full Text] [Related]
18. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Andrews TC; Ballantyne CM; Hsia JA; Kramer JH Am J Med; 2001 Aug; 111(3):185-91. PubMed ID: 11530028 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits. Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733 [TBL] [Abstract][Full Text] [Related]
20. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S; Gamez R; Mas R; Goicochea E Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]